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Abstract
The covalent binding of biotin to histones participates in heterochromatin formation, cell cycle progression and cellular response to DNA
breaks. Biotinylation of histones appears to be a reversible process, but the identity of enzymes that remove biotin marks is largely unknown.
Our long-term goal is to identify histone debiotinylases in human cells. Here we developed an avidin-based plate assay to quantify histone
debiotinylase activities in nuclear extracts. This assay is an essential first step in purifying and identifying histone debiotinylases from human
cells. Using this assay, we demonstrated that debiotinylation of histones depends on temperature and pH, consistent with enzyme catalysis.
Experiments with purified histones, proteases and protease inhibitors provide evidence that removal of biotin marks from histones is
mediated by debiotinylases rather than by proteases. Activities of histone debiotinylases varied among human
tissues: colon=lungNplacenta= liverN lymphoid cells. This assay proved useful in monitoring activities of putative histone debiotinylases
during their partial purification from cells. Collectively, this assay is a useful tool for investigating histone debiotinylases in human tissues.
D 2007 Elsevier Inc. All rights reserved.
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1. Introduction
The classical role of biotin in intermediary metabolism is
to serve as a covalently bound coenzyme for acetyl-CoA
carboxylase a, acetyl-CoA carboxylase h, pyruvate carbox-
ylase, propionyl-CoA carboxylase and 3-methylcrotonyl-
CoA carboxylase [1]. These enzymes play essential roles in
the metabolism of fatty acids, glucose and amino acids. In
addition, previous studied have provided evidence that the
activity of cell signals such as biotinyl-AMP, NF-nB, Sp1,
Sp3 and receptor tyrosine kinases depends on biotin [2–5].
Consistent with these observations, biotin and its catabolites
affect the expression of more than 2000 genes in human
lymphocytes and liver cells [6–8].
More recently, the quantity and the quality of the
biological functions of biotin have been expanded substan-
tially by the demonstration that histones H1, H2A, H2B, H3
andH4 contain covalently bound biotin [9,10]. The following
biotinylation sites have been identified: K9, K13, K125,
K127 and K129 in histone H2A [11]; K4, K9 and K18 in
histone H3 [12]; and K8 and K12 in histone H4 [13].
Biotinylation of histones is mediated by holocarboxylase
synthase [14] and biotinidase [9]. Evidence that biotinylation
of histones plays a role in cell proliferation [10], cellular
response to DNA damage [15], mitotic condensation of
chromatin [16] and heterochromatin structures and gene
silencing has been provided (Camporeale et al., submitted for
publication). Collectively, the binding of biotin to histones
participates in epigenetic events that are crucial for main-
taining genomic stability and chromatin structure [17].
Amino acid residues that are targets for covalent
modification in histones are exposed at the nucleosomal
surface in chromatin [18,19]. Lysine residues that are targets
for biotinylation are no exception to this rule [12,13,20].
Circumstantial evidence supporting that cells possess the
tools needed to remove biotin marks from these lysine
residues has been provided; enzymatic debiotinylation of
histones is a feasible mechanism for the modification of
chromatin structure in response to changes in the cellular
environment. For example, in JAr choriocarcinoma cells,
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K12 in histone H4 is rapidly debiotinylated in response to
double-strand breaks in DNA [15]. Likewise, K12 in histone
H4 is debiotinylated at the interleukin-2 locus in response to
mitogenic stimulation of lymphoid cells (Camporeale et al.,
submitted for publication). There is precedence for the
notion that removal of histone modifications plays a critical
role in the regulation of chromatin structure. For instance,
removal of acetyl residues by deacetylases is a known
hallmark of gene silencing [21].
The identity of enzymes capable of debiotinylating
histones is largely unknown. Evidence supporting that
biotinidase might catalyze both biotinylation [9] and
debiotinylation of histones has been provided [22]. How-
ever, it remains uncertain how the same enzyme may act as
a biotinyl transferase in one case and as a debiotinylase in
another. It has been proposed that regulation of biotinidase
is achieved by interactions with chromatin-associated
proteins, posttranslational modifications and alternative
splicing, and substrate availability [17]. Note that we have
detected biotinidase in human cell nuclei [11], whereas other
groups suggest that biotinidase is primarily an extranuclear
protein [23]. The identification of the exact role of
biotinidase in histone debiotinylation awaits further analysis
and depends on the availability of a reliable assay for
debiotinylase activity.
A long-term goal of our study is to identify histone
debiotinylases in human cells. As an important first step
towards achieving this goal, we have developed a microtiter
plate assay to quantify activities of histone debiotinylases in
nuclear extracts. Here, we provide data to validate this assay
and to provide first insights into debiotinylase activities in
human tissues. Importantly, we demonstrate that this assay
is a useful tool to monitor debiotinylase activities during
enzyme purification.
2. Materials and methods
2.1. Cell culture
The following cell lines were obtained from the
American Type Culture Collection (Manassas, VA): HepG2
hepatocarcinoma cells, JAr choriocarcinoma cells, Jurkat
lymphoma cells (clone E6-1) and NCI-H69 small cell lung
cancer cells. HCT116 epithelial cells derived from human
colorectal carcinoma were provided by B. Vogelstein (Johns
Hopkins University, Baltimore, MD). Cells were cultured in
a humidified atmosphere (5% CO2 at 378C) as described
previously [8,24–26]. Cell viability was monitored period-
ically with Trypan blue exclusion test [27].
2.2. Protein extracts
Proteins were extracted from the cell nuclei and
cytoplasm with Nuclear Extract Kit (Active Motif, Carlsbad,
CA) according to the manufacturer’s instructions. Protein
concentrations were determined with the bicinchoninic acid
method (Pierce, Rockford, IL).
2.3. Quantitation of histone debiotinylase activity
First, histone H1 from calf thymus (Calbiochem, La
Jolla, CA) was biotinylated enzymatically [13] to produce
substrates for histone debiotinylases in subsequent assays.
Briefly, 1 mg of histone H1 was dissolved in a mixture of
0.6 ml of human plasma (as a source of biotinyl transferase),
0.4 ml of 750 AM biocytin (biotinyl-q-lysine; as a source of
biotin) and 19 ml of 50 mM Tris buffer (pH 8.0); the
mixture was incubated at 378C for 45 min in a waterbath
[13]. In previous studies, using high-performance liquid
chromatography and mass spectrometry, we have confirmed
the covalent binding of biotin to histones [13]. Second,
96-well plates were coated with biotinylated histone
H1 as follows. Thirty milliliters of 50 mM carbonate buffer
(pH 9.6) was added to the histone solution from Step 1, and
100-Al aliquots of the mixture were dispensed into 96-well
plates for overnight coating at 48C. Coating efficiency
depended substantially on the brand of plate used. We
obtained best results using Falcon Microtest plates (Becton
Dickinson, Franklin Lakes, NJ), but readers are encouraged
to test various brands. Next, wells were washed with
phosphate-buffered saline (PBS; pH 7.4) and blocked with
200 Al of 0.1% bovine serum albumin (wt/vol) and 0.05%
Tween-20 (vol/vol) in PBS (pH 7.4) at 48C for at least 4 h.
The activities of histone debiotinylases were quantified as
follows. Coated and blocked plates were washed twice with
200 Al of PBS. Nuclear or cytoplasmic extracts were diluted
with water to produce a concentration of 2.5 Ag of protein
per 50 Al. Fifty microliters of diluted extracts was mixed
with 100 Al of 50 mM Tris buffer (pH 7.4), and samples
were transferred to microwell plates to initiate the enzymatic
debiotinylation of histones; incubation times, temperatures
and variations of buffers were as provided in Results.
Typically, protein-free Tris buffer was used as a negative
control, but other controls were also tested (see below).
Debiotinylation of histones was terminated by washing the
plates twice with 200 Al of PBS. The histone-bound biotin
remaining in the plates was probed with 100 Al of avidin-
conjugated horseradish peroxidase [10 Ag/L in PBS
containing 0.1% BSA (wt/vol)] at room temperature for
1 h. Plates were washed twice with 0.05% Tween-20 in PBS
(vol/vol). Bound horseradish peroxidase was quantified with
100 Al of SureBlue 3,3V,5,5V-tetra-methylbenzidine (TMB)
Microwell Peroxidase Substrate (KPL, Inc., Gaithersburg,
MD) at room temperature for 30 min; the reaction was
terminated by adding 100 Al of TMB Stop Solution (KPL,
Inc.) or 1 N hydrochloric acid. Absorbance was read at
450 nm with an Emax Microplate reader (Molecular
Devices, Sunnyvale, CA). Calibration curves were generat-
ed by incubating avidin-conjugated horseradish peroxidase
(up to 1.4 fmol/well) in histone-free plates with 100 Al of
TMB substrate. Calibration was based on the assumption
that, on average, one molecule of avidin is conjugated to
two molecules of horseradish peroxidase, producing a
molecular weight of 147 kDa. One unit of histone
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debiotinylase activity is defined as 1 pmol of biotin released
per milligram of protein for every 15 min.
2.4. Proteolytic digestion of histone H1
Theoretically, proteases present in tissue extracts could
nonspecifically cleave histone H1 in wells and introduce
artifacts in histone debiotinylase assay. To evaluate potential
proteolytic activities, 1 mg of histone H1 was dissolved in
100 Al of 20 mM sodium acetate buffer (pH 4.5). A volume
of acetate buffer containing 4 Ag of histone H1 was mixed
with 10 Al of 50 mM Tris buffer (pH 7.4) and 7 Al of nuclear
extract (containing 20 Ag of protein); samples were
incubated at 378C for 20 min. The following controls were
tested: (a) histone H1 incubated without nuclear extract, and
(b) histone H1 incubated with 6.25 ng of trypsin with or
without 20 mM of the trypsin inhibitor phenylmethylsulfo-
nylfluoride (PMSF). Reactions were terminated by heating
the samples with an equal volume of gel loading buffer
(Invitrogen, Carlsbad, CA) at 728C for 10 min. Proteins
were resolved with 4–12% bis-Tris gels (Invitrogen) as
described [10] and were visualized with Coomassie blue.
2.5. Partial purification of debiotinylases from
Jurkat cell nuclei
Using a hypotonic buffer from the above Nuclear Extract
Kit (Active Motif), we prepared whole-cell protein extracts
from Jurkat cells according to the manufacturer’s instruc-
tions; extracts were prepared in the presence of protease
inhibitor cocktail. Proteins were partially enriched by
fractional ammonium sulfate precipitation [28]; ammonium
sulfate was removed by two changes against 1000 vol of
50 mM Tris buffer (pH 7.4). Peak debiotinylase activities
were detected in 30–75% ammonium sulfate fraction, and
this fraction was used for further protein purification. Pro-
teins were resolved by anion exchange chromatography
(Q Sepharose; Amersham Pharmacia Biotech, Uppsala,
Sweden) and eluted with 0.5MNaCl in 50 mMTris (pH 7.4).
2.6. Statistical analysis
The homogeneity of variances among groups was
confirmed with Bartlett’s test [29]. The significance of
differences among groups was tested by one-way analysis of
variance. Fisher’s protected least significant difference
procedure was used for post hoc testing [29]. Student’s
paired t test was used for pairwise comparisons. StatView
5.0.1 (SAS Institute, Cary, NC) was used to perform all
calculations. Differences were considered significant if
Pb.05. Data are expressed as meanFS.D.
3. Results
3.1. Calibration and linearity of histone debiotinylase assay
The apparent oxidation of TMB increased linearly up to
0.7 fmol/well avidin–horseradish peroxidase, as judged by
absorbance at 450 nm (Fig. 1). Subsequent histone
debiotinylation assays were calibrated using avidin stand-
ards from within the linear range. For calibration purposes,
it was assumed that one molecule of avidin binds four
molecules of biotin [30]. This might slightly overestimate
the amount of biotin released by histone debiotinylases,
given that not all biotin-binding sites in avidin might
participate in biotin binding due to spatial effects [31].
Incubation of 96-well plates with nuclear extracts from
NCI-H69 cells caused a time-dependent and protein-
dependent release of biotin from histone H1. This is con-
sistent with the presence of histone debiotinylases in human
cell nuclei. The release of biotin was linear up to about
5 Ag/well nuclear protein (Fig. 2). If the mass of pro-
tein exceeded 5 Ag/well, we observed an artificial rapid
bdebiotinylationQ of histones during the first 5 min of
incubation. This apparent rapid debiotinylation could not be
blocked by heat inactivation of nuclear extracts or by
incubation of plates at 48C and, hence, was not an enzyme-
Fig. 1. Spectrophotometric quantitation of TMB oxidation. The oxidation of
TMB in SureBlue TMB Microwell Peroxidase Substrate (100 Al/well)
increased linearly up to 0.7 fmol/well avidin–horseradish peroxidase.
Fig. 2. Histone debiotinylation depends on the amount of nuclear protein
and incubation time. Histone H1-coated plates were incubated with nuclear
protein from NCI-H69 cells, and rates of histone debiotinylation were
quantified at timed intervals at pH 7.4 and 378C (n =3 for each data point).
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mediated process. In contrast, if plates were incubated with
up to 5 Ag/well protein, histone debiotinylation exhibited all
characteristics of enzyme-mediated processes (see below).
Consequently, all assays described below were conducted
using 2.5 Ag/well nuclear protein for 15 min. In a typical
experiment, the activity of histone debiotinylases in NCI-
H69 nuclei equaled 0.7F0.2 U. The signal-to-noise ratio of
our assay was approximately 24:1.
3.2. Debiotinylation characteristics
Debiotinylation of histones by nuclear extracts is an
enzyme-mediated process, rather than a result of the
artificial desorption of histone H1 from plastic surfaces,
based on the following line of observations. First, debioti-
nylation of histone H1 by nuclear extracts from NCI-H69
cells was temperature-dependent: 0.7F0.03 U at 378C
versus 0.4F0.02 U at 48C (Pb.05; n=3). Second, heating
nuclear extracts at 908C abolished histone debiotinylase
activity. Third, debiotinylation of histone H1 was not
detectable if plates were incubated with protein-free nuclear
extraction buffer. Fourth, the rate of histone debiotinylation
depended on the pH of an incubation buffer (Fig. 3). Here,
pH values in the incubation buffer varied between 3.5 and
10, using buffers based on 100 mM (final concentration)
sodium acetate (pH 3.5–5), 100 mM 2-(N-morpholino)e-
thanesulfonic acid (pH 6–7) and 100 mM Tris (pH 8–10)
buffer. Two pH optima were observed for histone debioti-
nylation in nuclei, consistent with multiple enzymes
mediating the release of biotin from histones. The first pH
optimum was between 4.0 and 4.5. The second pH optimum
was between 7.5 and 8.0. The latter is similar to the pH in
the nuclear compartment and is similar to the pH optimum
of the aminohydrolase biotinidase [28]. Given the known
role of biotinidase in debiotinylation reactions, the majority
of subsequent studies were conducted at pH 7.4.
3.3. Proteolysis
To exclude the potential proteolytic degradation of histone
as a source of error in our assays, commercial histone H1 was
incubated with nuclear extract from NCI-H69 cells, and the
electrophoretic pattern of histone H1 was observed in
Coomassie-blue-stained gels. The majority of histone H1
remained intact during incubation with nuclear extracts
(Fig. 4, Lanes 1 and 2). The sample containing both histone
H1 and nuclear extract (Lane 1) produced multiple extra
bands compared with the sample containing only histone H1
(Lane 2). These bands represented nuclear proteins rather
than breakdown of histone H1. This notion is based on the
observation that a sample containing nuclear extract but no
supplemental histone H1 produced a staining pattern similar
to the supplemental sample with histone H1 (compare Lanes
1 and 3). Histone H1 was degraded when it was incubated
with 6.25 ng of trypsin (Lane 4; positive control); degradation
Fig. 3. Debiotinylation of histone H1 by nuclear extracts from NCI-H69
cells depended on the pH of the incubation buffer. Rates of debiotinylation
were quantified at 378C for 15 min (n =3).
Fig. 4. Release of biotin by proteolytic degradation of histone H1 was
quantitatively minor. Lane 1=histone H1 incubated with nuclear extract
from NCI-H69 cells (378C, 20 min). Lane 2=native histone H1 incubated
in the absence of nuclear extract. Lane 3=nuclear extract from NCI-H69 in
the absence of exogenous histone H1. Lane 4=histone H1 incubated with
6.25 ng of trypsin (378C, 20 min). Lane 5=histone H1 incubated with
trypsin in the presence of 20 mM PMSF (378C, 20 min). Proteins were
resolved by gel electrophoresis and stained with Coomassie blue.
Fig. 5. Activities of histone debiotinylases in nuclear extracts from human
cells depended on the tissue from which cells originated. Nuclear extracts
were prepared from HCT116 colorectal carcinoma, NCI-H69 small lung
cancer, JAr choriocarcinoma, HepG2 hepatocarcinoma and Jurkat lympho-
ma cells, and debiotinylase activities were quantified by plate assay at pH
7.4. a,b,cColumns not sharing the same letter are significantly different
( P b.05; n =3).
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by trypsin was inhibited with the trypsin inhibitor PMSF
(Lane 5). Note that the extraction buffer used for the
preparation of nuclear extracts contains protease inhibitors,
consistent with minimal, if any, proteolysis in debiotinylation
assays. Collectively, we cannot formally exclude the possi-
bility that proteases account for some removal of biotin marks
from histones. However, our data strongly suggest that
debiotinylases, rather than proteases, account for histone
debiotinylation (see Discussion).
3.4. Tissue distribution and cellular localization
Histone debiotinylases exhibited a tissue-specific pattern
of distribution. Of all tissues tested, NCI-H69 lung cancer
cells and HCT116 human colorectal carcinoma epithelial
cells exhibited the highest debiotinylase activities (Fig. 5).
Debiotinylase activities in HepG2 hepatocarcinoma cells
and JAr choriocarcinoma cells were about 50% smaller than
those in NCI-H69 cells, and activities in Jurkat lymphoid
cells were about 70% smaller than those in NCI-H69 cells.
The activity of histone debiotinylases was greater in cell
nuclei than in the cytoplasm. For example, debiotinylase
activity was 0.8F0.04 U in nuclei from NCI-H69 cells, but
only 0.3F0.03 U in cytoplasmic extracts (Pb.05; n=3).
3.5. Partial purification of histone debiotinylases
The assay developed here is a useful tool to monitor
activities of histone debiotinylases during the purification of
cellular proteins. Here, we used ammonium sulfate precip-
itation and anion exchange chromatography to achieve partial
purification. Peak debiotinylase activities were detected in
fractions obtainedwith 30–75% ammonium sulfate and anion
exchange fractions eluted with 0.5 M NaCl. Overall, we
achieved a fourfold purification of human histone debiotiny-
lases (Fig. 6). Purification of histone debiotinylases to
homogeneity was beyond the scope of this study but will
be pursued in future investigations. Note that the precipitation
of histone debiotinylase in 30–75% ammonium sulfate
fraction was fairly similar to the known enrichment of
biotinidase [28] — an enzyme suspected to have histone
debiotinylase activity [22].
4. Discussion
Here we present an avidin-based assay to quantify
activities of histone debiotinylases. Using this assay, we
provide evidence (a) that human cell nuclei contain proteins
with histone debiotinylase activity; (b) that debiotinylation of
histones is mediated by debiotinylases rather than by
proteases; (c) that histone debiotinylases are enriched in the
nuclear compartment; and (d) that the activities of histone
debiotinylases are greater in cells derived from the lungs and
the colon than in cells derived from the lymphatic system,
liver and placenta. Importantly, we also provide evidence that
this assay is a useful tool to achieve our long-term goal (i.e.,
the identification of histone debiotinylases in human cells).
These findings are biologically relevant, given the
following observations from previous studies. First, biotiny-
lation of histones plays a role in cell proliferation [10,14],
cellular response to DNA damage [15], mitotic condensation
of chromatin [16] and heterochromatin structures and gene
silencing (Camporeale et al., submitted for publication).
Abnormal patterns of histone biotinylation might cause some
of the events known to be associated with biotin deficiency
(e.g., fetal malformations) [32]. Histone debiotinylation
likely plays an important role in chromatin remodeling
events. For example, biotin marks are rapidly removed from
K12 in histone H4 in response to DNA double-stranded
breaks [15] and gene activation (Camporeale et al., submitted
for publication). Relatively little is known about the enzymes
that mediate the removal of biotin marks from histones. The
assay presented here breaks ground for future investigations
of histone debiotinylases. Second, biotinidase is suspected to
play a role in histone debiotinylation [22]. Inborn errors
causing biotinidase deficiency are fairly common in humans.
The estimated incidence of profound biotinidase deficiency
(b10% of normal biotinidase activity) is 1 in 112,000 live
births, and the incidence of partial biotinidase deficiency
(b30% of normal biotinidase activity) is 1 in 129,000 [33].
The combined incidence of profound and partial deficiency
is 1 in 60,000 live births; an estimated 1 in 123 indivi-
duals is heterozygous for the disorder [33]. Mutations of
the biotinidase gene have been well characterized at
the molecular level [34–36]. It remains to be determined
whether biotinidase deficiency causes abnormalities in
chromatin structure. The assay presented here will facilitate
these studies.
In the present study, nuclear histone debiotinylases
exhibited two pH optima; the first pH optimum was about
4.0–4.5, and the second pH optimum was about 7.5–8.0.
Fig. 6. Semipurification of histone debiotinylases from Jurkat cells. Proteins
were fractionated with 30–75% ammonium sulfate and anion exchange
chromatography (0.5 M NaCl). Specific activities of histone debiotinylase
were quantified in crude cell extracts and ammonium sulfate fractions, and
fractions were collected by anion exchange chromatography. a,bColumns
not sharing the same letter are significantly different ( P b.05; n =3).
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Notwithstanding the putative role of biotinidase in histone
debiotinylation, we cannot formally exclude the possibility
that enzymes other than biotinidase also mediate debiotiny-
lation of histones. Biotinidase belongs to the nitrilase super-
family of enzymes, which consists of 12 families of amidases,
N-acyltransferases and nitrilases [37]. Some members of the
nitrilase superfamily (vanin-1, vanin-2 and vanin-3) share
significant sequence similarities with biotinidase [38]. The
assay developed here is likely to generate insights into the
potential roles of enzymes other than biotinidase in histone
debiotinylation and chromatin structure.
We shall point out the following uncertainties associated
with the studies presented here. First, proteolytic degrada-
tion of histone was monitored by staining gels with
Coomassie blue. This assay may lack the sensitivity to
detect quantitatively minor proteolysis events. In addition,
proteolytic removal of only a few amino acids from histone
H1 may cause only a minor shift in electrophoretic mobility
that is too small for detection. Second, our assay has the
same limitation as many other plate assays for histone
modifications: enzyme activities are quantified in an
isolated system rather than in chromatin context. We cannot
formally exclude the possibility that proteins interacting
with debiotinylases cause meaningful alterations of debio-
tinylase activity. Third, the enzymatic biotinylation of
histone H1 during substrate synthesis was likely associated
with biotinylation of various sites in histone H1. The
identity of these sites is unknown. We are currently in the
process of developing biotinylation site-specific assays for
histone debiotinylases. These assays target known biotiny-
lation sites in histone H2A, H3 and H4 that have been
identified in our previous studies [11–13]. These limitations
notwithstanding, we anticipate that the histone debiotinylase
assay presented here will permit identification of novel
nuclear debiotinylases and will help generate insights into
biotin-dependent chromatin remodeling events.
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